News Column

Researchers at University Institute of Pharmacy Release New Data on Drug Delivery Systems

June 18, 2014

By a News Reporter-Staff News Editor at Biotech Week -- Researchers detail new data in Drugs and Therapies. According to news reporting out of Raipur, India, by NewsRx editors, research stated, "Approximately 95% of the population suffers at some point in their lifetime from acne vulgaris. Acne is a multifactorial disease of the pilosebaceous unit."

Our news journalists obtained a quote from the research from the University Institute of Pharmacy, "This inflammatory skin disorder is most common in adolescents but also affects neonates, prepubescent children, and adults. Topical conventional systems are associated with various side effects. Novel drug delivery systems have been used to reduce the side effect of drugs commonly used in the topical treatment of acne. Topical treatment of acne with active pharmaceutical ingredients (API) makes direct contact with the target site before entering the systemic circulation which reduces the systemic side effect of the parenteral or oral administration of drug. The objective of the present review is to discuss the conventional delivery systems available for acne, their drawbacks, and limitations. The advantages, disadvantages, and outcome of using various carrier-based delivery systems like liposomes, niosomes, solid lipid nanoparticles, and so forth, are explained."

According to the news editors, the research concluded: "This paper emphasizes approaches to overcome the drawbacks and limitations associated with the conventional system and the advances and application that are poised to further enhance the efficacy of topical acne formulations, offering the possibility of simplified dosing regimen that may improve treatment outcomes using novel delivery system."

For more information on this research see: Carrier-based drug delivery system for treatment of acne. Thescientificworldjournal [electronic Resource], 2014;2014():276260 (see also Drugs and Therapies).

Our news journalists report that additional information may be obtained by contacting A. Vyas, University Institute of Pharmacy, Pandit Ravishankar Shukla University, Raipur 492 010, India. Additional authors for this research include A. Kumar Sonker and B. Gidwani.

Keywords for this news article include: Asia, India, Raipur, Drugs and Therapies, Drug Delivery Systems.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Biotech Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters